Articles published by SAGA Diagnostics

SAGA Diagnostics Announces NeoCircle Publication Demonstrating the Prognostic Value of ctDNA Dynamics in Early Breast Cancer

May 26, 2026

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics to Present Data on Ultrasensitive Pathlight™ MRD Test in Breast, Colon, and Rectal Cancers at ASCO 2026

May 22, 2026

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics to Present New Pathlight™ MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026

April 17, 2026

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer

January 12, 2026

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics® Presents Real-World Pathlight™ MRD Data at ASCO GI 2026

January 07, 2026

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics’ Pathlight™ MRD Further Demonstrates Clinical Validity In TNBC Trials Presented at SABCS

December 09, 2025

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics Showcases New Pathlight™ MRD Data at SABCS 2025

December 01, 2025

From SAGA Diagnostics

Via Business Wire

Saga Diagnostics to Present at Jefferies Global Healthcare Conference in London

November 18, 2025

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes

July 30, 2025

From SAGA Diagnostics

Via Business Wire

SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection

May 27, 2025

From SAGA Diagnostics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Articles published by SAGA Diagnostics

Starting at $3.75/week.

Subscribe Today